drugmaker

简明释义

英[ˈdrʌɡˌmeɪkə]美[ˈdrʌɡˌmekər]

n. 制药者

英英释义

单词用法

同义词

反义词

例句

1.The giant drugmaker has taken a hit from the stronger dollar, a particular concern for the company because 54% of its sales come from foreign markets.

特别令人关注的是这家制药巨头受到美元走强的打击，因为该公司54%的销售额来自海外市场。

2.Nonetheless, taking over Wyeth would cement Pfizer's position as the world's leading drugmaker.

尽管如此，并购惠氏制药将巩固辉瑞制药世界最大制药商的地位。

3.The news on Monday January 26th that Pfizer, the world's biggest drugmaker, is bidding for Wyeth, a large American rival, should provide a welcome tonic for some.

1月26日，世界上最大的制药商辉瑞制药正竞标收购其美国对手惠氏制药，这一消息受到许多人的欢迎。

4.Sanofi, the world's third-largest drugmaker, already has a significant commercial presence in China and is conducting many clinical trials in the country.

赛诺菲，作为世界第三大制药公司，在中国已经有一个重要的商业地位，并正在进行多项临床试验。

5.The drugmaker added that the EMS impurities were caused by the manufacturing process of the drug, which is known generically as nelfinavir mesylate.

药品制造商补充说，EMS杂质在药物生产过程中产生，通常认为是甲磺酸奈非那韦。

6.The 30 largest Swiss companies reported earnings growth of 38 percent during the past four years, buoyed by exports from watchmaker Swatch Group AG, Nestle and drugmaker Novartis AG.

据报道，过去四年中，由于手表制造商斯沃琪集团，雀巢以及制药公司诺华股份有限公司的拉动，瑞士前30强公司收益增长率高达38%。

7.And the new Japan has some old members: Ono Pharmaceutical, a drugmaker with margins of 37% between 2000 and 2009, was founded in 1717.

新日本成员中叶有些老企业：制造企业——小野药业，成立于1717,2000 - 2009年的利润率高达37%。

8.Pfizer, the world's biggest drugmaker, wants to get even bigger by taking over Wyeth, a rival.

世界最大的制药商，辉瑞制药，意图收购对手惠氏制药以变得更大。

9.A major drugmaker 制药商 is collaborating with universities to develop innovative therapies.

一家大型制药商正在与大学合作开发创新疗法。

10.Many drugmakers 制药商 are investing in research for new vaccines.

许多制药商正在投资研究新疫苗。

11.The drugmaker 制药商 faced lawsuits over the side effects of its medication.

这家制药商因其药物的副作用面临诉讼。

12.The drugmaker 制药商 received FDA approval for its new drug.

这家制药商的新药获得了FDA的批准。

13.The drugmaker 制药商 announced a breakthrough in cancer treatment.

这家制药商宣布在癌症治疗方面取得了突破。

作文

The pharmaceutical industry plays a crucial role in modern healthcare, and at the heart of this industry are the drugmakers. These companies are responsible for the research, development, and production of medications that save lives and improve the quality of life for millions of people around the world. A drugmaker (药品制造商) is not just a business entity; it is a vital contributor to public health and wellness. In recent years, the importance of drugmakers has become even more pronounced due to global health crises, such as the COVID-19 pandemic. The rapid development of vaccines and treatments showcased the remarkable capabilities of drugmakers to respond to urgent health needs. Companies like Pfizer, Moderna, and AstraZeneca have set an example of how innovation can lead to life-saving solutions in record time. This swift response was possible because of years of investment in research and development, which is a hallmark of successful drugmakers. However, the journey of a drugmaker is not without challenges. The process of bringing a new drug to market is long and complex, often taking over a decade and costing billions of dollars. It involves rigorous testing phases, including preclinical trials and multiple phases of clinical trials, to ensure safety and efficacy. Regulatory bodies like the FDA in the United States play a critical role in overseeing this process, providing a necessary check on the practices of drugmakers to protect public health. Moreover, ethical considerations are paramount in the operations of drugmakers. There is an ongoing debate about drug pricing and accessibility. While drugmakers argue that high prices are necessary to recoup research and development costs, many advocates stress the need for affordable medications, especially in low-income countries. This tension highlights the delicate balance that drugmakers must maintain between profitability and social responsibility. Another significant aspect of the work done by drugmakers is their commitment to innovation. The landscape of medicine is constantly evolving, with new diseases emerging and existing ones becoming resistant to current treatments. Drugmakers are at the forefront of this battle, investing in cutting-edge technologies such as gene therapy, personalized medicine, and artificial intelligence to develop next-generation therapies. This innovative spirit is essential for addressing the health challenges of today and tomorrow. In conclusion, drugmakers (药品制造商) are indispensable players in the healthcare system. Their contributions extend far beyond the creation of medications; they embody the intersection of science, ethics, and social responsibility. As we move forward, it is crucial to support and hold drugmakers accountable, ensuring that they continue to innovate while also prioritizing the health and well-being of the global population. The future of medicine depends on their ability to navigate these complex issues effectively.